HomeAnnual MeetingsNext meetingAnnual Meetings

2024 IACR Scientific Conference

The 2024 IACR Scientific Conference will be held in Beijing, China and will be hosted by the National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences, in the 4th quarter of 2024.  Conference dates will be announced in January 2024 at the latest.

2024 template1

 

 

2023 IACR & ENCR Scientific Conference

The Joint ENCR - IACR Scientific Conference 2023

held on 13-16 November 2023, Granada, Spain

1Banner Scientific Conference ENCR IACR 2023

 

Conference Topics

  1. COVID 19 - impact on cancer surveillance, services, and outcomes

  2. Stage, comorbidities, and other prognostic information in cancer registration

  3. Clinical applications - treatment, recurrence, and other outcomes

  4. Descriptive epidemiology including special populations (e.g., children, adolescents and young adults)

  5. Registry innovations, research, and health policy. 

 

Pre-Conference Workshops (13 November 2023)

ENCR has put together four (4) pre-conference workshops held  13 November.  

WORKSHOP 1 (09:00-12:30): Registration of treatment variables in Population-Based Cancer Registries

WORKSHOP 2 (9:00-12:30): Population-based cancer survival metrics

WORKSHOP 3 (13:30-17:00): Recurrences

WORKSHOP 4 (13:30-17:00): IT tools and novel AI approaches for cancer registration

More information and updates here:  2023 ENCR-IACR Scientific Conference

IACR 2022 Virtual Scientific Conference

International Association of Cancer Registries 2

 

KEYNOTE PRESENTATIONS WERE GIVEN BY:

 

Recording Cancer Stage in Australian Registries
by Prof David Roder
International Sharing of Cancer Data for Cancer Research
by Dr Giske Ursin on the EU GDPR
Progress in Cancer Registration in China
by Prof Wenqiang Wei
Cancer Surveillance and Indigenous Populations in the United States
by Dr Charles Wiggins
 

PLENARY TOPICS:

 
  • Cancer staging
  • Children, adolescents, young adults’ cancer surveillance and follow-up
  • Collaboration, innovation and training in registry practice
  • Covid-19 pandemic and its impact on registries, health services, and outcomes
  • Registries, research and health policy

2023 Joint IACR-ENCR Scientific Conference

2023ENCR IACR Granada

2023 Conference Overview

2023Topics

 

 

 

 

2023 ENCR IACR Scientific Conference Web1

IACR 2017 - Utrecht

 

Conference Book of abstracts

 

39th Annual Scientific Conference

17-19 October 2017, Utrecht, The Netherlands

Ensuring quality and use of data from cancer registries in the 21st century

iacr 2017

The 39th Annual meeting was held in Utrecht (The Netherlands) from 17 to 19 October 2017.

The main theme of the meeting was Ensuring quality and use of data from cancer registries in the 21st century.

Acknowledging the diversity of cancer registries worldwide: methods, longevity, data integration and practice.

Responding to future challenges in sustaining cancer registries.

 

Plenary Themes:

  • Cancer surveillance for cancer control
  • The role of cancer registries in prevention and screening programmes
  • The role and integration of cancer registries in clinical outcomes
  • Analysing, presenting and communicating cancer registry data
  • Cancer registries and ‘big data’: the next generation of studies

Keynote Speakers:

  • Prof Jack Siemiatycki, University of Montreal, Clemmesen Lecturer
  • Prof. Karin Haustermans, UH Leuven
  • Prof. Johan Mackenbach, Erasmus MC, Rotterdam
  • Dr. Kevin Ward, Georgia Center for Cancer Statistics, Emory University
  • Dr. Isabelle Soerjomataram, International Agency for Research on Cancer

Announce1 39IACR

BCRandIKNL logo 


THE CLEMMESEN LECTURE

The 6th Johannes Clemmesen Lecture was delivered by Jack Siemiatycki.

THE ENRICO ANGLESIO PRIZE

The 8th prize was awarded to Simone Versteeg from Utrecht (The Netherlands) for her presentation on the study: "Centralisation of cancer surgery and the impact on patients’ travel burden".

Our partners

120507 01b LOGO X3

 

iarc-logo

 

encr-logo

This website was developed and is hosted at the International Agency for Research on Cancer (IARC)
Go to top